<DOC>
	<DOC>NCT00610363</DOC>
	<brief_summary>This is a clinical research study to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning another additional treatment. Subjects will participate in this study for approximately 24 weeks. Rilonacept is being studied for use in preventing gout attacks in patients who have gout.</brief_summary>
	<brief_title>Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares</brief_title>
	<detailed_description />
	<mesh_term>Gout</mesh_term>
	<criteria>Male or female greater than 18 years of age Previously met the preliminary criteria of the ARA for the classification of the acute arthritis of primary gout At least 2 gout flares in the year prior to the Screening Visit Acute gout flare within 2 weeks of the Screening visit and during Screening Persistent chronic or active infections History of an allergic reaction to allopurinol History or presence of cancer within 5 years of the Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>